Gemma Jimenez-Moreno

Madrid, MD 28034, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Apheresis CD8+CCR7+CD45RA- T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.

Apheresis CD8+CCR7+CD45RA- T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.

Journal: International journal of molecular sciences

Published: December 04, 2025

Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia.

Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia.

Journal: Frontiers in oncology

Published: March 01, 2024

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.

Journal: Blood

Published: February 08, 2024

ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy.

ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy.

Journal: Blood

Published: October 02, 2023

Prediction of blood volume to be processed to achieve a target number of CD34+ cells: Development, validation and implementation of a formula.

Prediction of blood volume to be processed to achieve a target number of CD34+ cells: Development, validation and implementation of a formula.

Journal: Vox sanguinis

Published: September 23, 2022

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.

Journal: Nature medicine

Published: August 25, 2022

Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.

Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.

Journal: Hematological oncology

Published: June 05, 2022

Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease.

Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease.

Journal: American journal of hematology

Published: April 10, 2021

Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH).

Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH).

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: November 10, 2020

Transfusion support in COVID-19 patients: Impact on hospital blood component supply during the outbreak.

Transfusion support in COVID-19 patients: Impact on hospital blood component supply during the outbreak.

Journal: Transfusion

Published: June 14, 2020

Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19.

Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19.

Journal: Bone marrow transplantation

Published: May 08, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026